MedTrace Logo

Virtual Reality for Generalized Anxiety Disorders

NCT05895721 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-07-08

No results posted yet for this study

Summary

The goal of this clinical trial is to apply Virtual Reality as an adjunct treatment for Generalized Anxiety Disorder. The main question it aims to answer are:

* Determination of the efficacy of VR modules as an adjunct therapy in improving GAD-7 scores
* Assessment of the acceptability of VR modules as an adjunct therapy to the standard of care

Participants will randomized into two arms:

* Control Arm: Standard of Care only
* Intervention Arm: Standard of Care + VR Modules

Conditions

  • Generalized Anxiety Disorder

Interventions

OTHER

Virtual Reality

Virtual Reality as adjunct treatment

Sponsors & Collaborators

  • Clinical Research Centre, Malaysia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05895721 on ClinicalTrials.gov